Blackmores Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blackmores Limited with three other
pharmaceutical manufacturers in Australasia:
Promisia Integrative Ltd
of New Zealand
sales of 2.67 million New Zealand Dollars [US$1.86 million]
(1.19 million Australian Dollars [US$887,963.34 ]
TBG Diagnostics Ltd
(2.70 million Australian Dollars [US$2.02 million]
of which 100%
was In Vitro Diagnostics).
Blackmores Limited reported sales of A$717.21 million (US$536.43 million)
June of 2016.
increase of 52.1%
versus 2015, when the company's sales were A$471.62 million.
Sales at Blackmores Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 206%).